Zhijuan Wu
P.R. China
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
S-1 maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis.
Journal: Science progress
Published: December 22, 2023
Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study.
Journal: Translational cancer research
Published: May 28, 2023
Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study.
Journal: Annals of translational medicine
Published: November 23, 2022
Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression.
Journal: Cancer management and research
Published: April 08, 2020
Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma.
Journal: Oncology research and treatment
Published: June 12, 2019
The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis.
Journal: OncoTargets and therapy
Published: May 08, 2018
Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer.
Journal: Oncology letters
Published: June 26, 2017
Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells.
Journal: Oncology letters
Published: November 14, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026